Back to Search
Start Over
Boundless Bio opens at $14.25, IPO priced at $16 per share
- Source :
- The Fly. March 28, 2024
- Publication Year :
- 2024
-
Abstract
- Boundless Bio (BOLD) priced 6.25M shares at $16.00. The deal priced at the midpoint of the $15.00-$17.00 target range. Boundless Bio is a clinical stage oncology company interrogating extrachromosomal DNA, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.787986239